continued injection policy and the unresolved fiscal problems of certain European countries are seen as the key drivers of continuous capital inflows into emerging markets including Thailand. However

, a changing trend can be seen as employers want an alternative for their employees by cancelling the former provident fund, which only consists of one policy, and shifting to another type of

. According to the increased of the market competition both of the competitor and the pricing, some projects could not continue to extend the services. However, the Private sector’s customer has continued

experiencing the lowest revenue due to the temporary closure of our operations because of the Covid-19, however the recovery of production volume was seen at end of the 3rd quarter, continuing with favorable

, and 1,722.70 million baht for year 2016, 2017, and 2018 respectively. As can be seen, the revenue from sale increased continuously every year. In the year 2018, increased orders and the market expansion

by 275.91% to Baht 221.90 million as compared to 2017 net profit in the amount of Baht 59.03 million. The aforementioned changes in the financial performance are summarized as seen in the below table

decreased by 45.02% to Baht 121.99 million as compared to 2018 net profit in the amount of Baht 221.90 million. The aforementioned changes in the financial performance are summarized as seen in the below

71.44 70.09 Proportion of cost of administrative expenses/revenue of medical treatment 12.54 13.13 It can be seen that the proportion of cost of medical treatment and administrative expenses / revenue of

by 23.8% to Baht 59.03 million as compared to 2016 net profit in the amount of Baht 77.47 million. The aforementioned changes in the financial performance are summarized as seen in the below table

medical treatment 67.53 69.02 Proportion of cost of administrative expenses/revenue of medical treatment 12.72 12.17 It can be seen that the proportion of cost of medical treatment and administrative